Atlas Trials

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Clinical trial NCT02948946 · COMPLETED

Trial details

NCT number
NCT02948946
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm
Start date
2017-01-09
Primary completion
2018-08-24
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.